comparemela.com

Latest Breaking News On - நிறுவனம் ஆஃப் மரபியல் ஒருங்கிணைந்த உயிரியல் - Page 4 : comparemela.com

Maharashtra: 21 Covid patients with Delta+ variant were not vaccinated? | Mumbai News

COVID-19: CSIR To Carry Out Genome Sequencing Of Samples From Maharashtra On A Regular Basis

COVID-19: CSIR To Carry Out Genome Sequencing Of Samples From Maharashtra On A Regular Basis DNA Helix (Pixabay) In a major step in the ongoing Covid-19 second wave, the Council of Scientific & Industrial Research (CSIR) will carry out genome sequencing of samples from Maharashtra on a regular basis, an officials said on Friday (30 April). The Maharashtra government has signed a MoU with the CSIR s Institute of Genomics & Integrative Biology (IGIB) for the project estimated to cost around Rs 1.62 crore. According to the agreement, the ICIB will collect around 100 samples from 25 districts in the state witnessing Covid positivity every month and send them for genome sequencing as part of a 3-month long research initiative, said Additional Chief Secretary, Health, Dr Pradeep Vyas.

Covid: CSIR to carry out genome sequencing for Maha

Covid: CSIR to carry out genome sequencing for Maha ​ By IANS | Published on ​ Fri, Apr 30 2021 19:18 IST | ​ 3 Views 64 full human genomes sequenced at high-res. Image Source: IANS News Mumbai, April 30 : In a major step in the ongoing Covid-19 second wave, the Council of Scientific & Industrial Research (CSIR) will carry out genome sequencing of samples from Maharashtra on a regular basis, an officials said on Friday. The Maharashtra government has signed a MoU with the CSIR s Institute of Genomics & Integrative Biology (IGIB) for the project estimated to cost around Rs 1.62 crore. According to the agreement, the ICIB will collect around 100 samples from 25 districts in the state witnessing Covid positivity every month and send them for genome sequencing as part of a 3-month long research initiative, said Additional Chief Secretary, Health, Dr. Pradeep Vyas.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.